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Abstract
Our daily life is not solely composed of a calm resting state but is rather 
full of perturbations that induce active states such as moving, eating, com-
municating, and so on. During such active conditions, cardiorespiratory 
regula tion should be adjusted according to the body’s demand, which 
differs from that during a resting state, by modulating or resetting the oper-
ating point. To explore the neural mechanisms of state-dependent adjust-
ment of central autonomic regulation, we focused on the stress-induced 
defense (fight-or-flight) response because stressors induce not only cogni-
tive, emotional and behavioral changes but also autonomic changes. In 
this mini-review, we summarize our recent discovery using orexin knock-
out mice and orexin neuron-ablated mice of the possible contribution of 
orexin, a hypothalamic neuropeptide, in the state-dependent adjustment 
of central autonomic regulation. The diversity of synaptic control of the 
cardiovascular and respiratory neurons seems necessary for animals to 
adapt themselves toward ever-changing life circumstances and behavioral 
states. The orexin system is likely to work as one of the essential modulators 
for coordinating circuits controlling autonomic functions and behavior. 
[Tzu Chi Med J 2008;20(2):82–90]
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1. Introduction
Fundamental neural substrates participating in the 
central autonomic regulation of circulation and respira-
tion have been established. For example, rostral ven-
trolateral medulla and pre-Bötzinger complex have 
been revealed as the sympathetic and respiratory cen-
ters, respectively, that are indispensable for mainte-
nance of our life [1,2]. We have abundant, though not 
complete, knowledge of the homeostatic mechanisms 
that stabilize circulation and respiration around an 
operating point at a resting state.
Our daily life, however, is not solely composed of 
a calm resting state. It is rather full of perturbations 
that induce active states such as moving, eating, com-
municating, and so on. During such active conditions, 
cardiorespiratory regulation should be adjusted ac-
cording to the body’s demand that differs from that 
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during a resting state by modulating or resetting the 
operating point [3]. Research on the adjustment mech-
anism has been relatively sparse, although it is impor-
tant from the quality-of-life point of view.
To explore the neural mechanisms of state-
dependent adjustment of central autonomic regula-
tion, we have recently focused on the stress-induced 
defense (fight-or-flight) response because stressors 
induce not only cognitive, emotional and behavioral 
changes but also autonomic changes. These changes 
include increases in blood pressure, heart rate, muscle 
blood flow, respiratory frequency, tidal volume, and 
body temperature and suppression of the barorecep-
tor reflex and pain sensitivity. Although research on the 
neural circuits underlying these changes has implicated 
the hypothalamus as the key structure in the defense 
response (Fig. 1), the neurotransmitters involved in 
this multifaceted and coordinated response have not 
been revealed.
2. Orexin
Orexins (orexin-A and orexin-B), also known as hypo-
cretins (hypocretin-1 and hypocretin-2, respectively), 
were identified as a ligand for a G-protein coupled 
orphan receptor in 1998. They are cleaved from a 
common precursor molecule, prepro-orexin (130 res-
idues), forming orexin-A (33 amino acids) and orexin-B 
(28 amino acids) [4,5]. Orexin-containing cell bodies 
are restrictedly located in the lateral hypo thalamus, 
the perifornical area (PFA), and the dorsomedial hypo-
thalamus (DMH). On the other hand, orexin-containing 
fibers and terminals are widely distributed in the hypo-
thalamus, thalamus, cerebral cortex, circumventricular 
organs, brain stem and spinal cord, suggesting that 
the orexinergic neurons have widespread connections 
with other brain regions [6,7]. This anatomic feature 
establishes the basis for contributions by orexin to the 
control of multiple physiological functions, including 
feeding behavior, energy homeostasis, sleep-wake cycle, 
and regulation of the autonomic and neuroendocrine 
systems [5,8–10].
3. Emotional behavior
Animals cope with stressors by two strategies. An 
active coping strategy (fight or flight) is evoked if 
the stress is predictable, controllable, or escapable. 
A passive coping strategy (immobility or decreased 
respon siveness to the environment) is evoked if the 
stress is inescapable. The active strategy is associ-
ated with sympathoexcitation (hypertension, tachy-
cardia), whereas the passive strategy is associated 
with sympathoinhibition and/or parasympathetic ac-
tivation (hypotension, bradycardia). The passive strat-
egy also helps to facil itate recovery and healing. The 
active strategy is also called the fight or flight re-
sponse from a behavioral point of view or defense 
response from an autonomic point of view. The pas-
sive strategy is sometimes called playing dead or 
paradoxical fear. Distinct neural substrates mediat-
ing active versus passive emotional coping have 
been identified within the brainstem [11,12]. In the 
posterior hypothalamus, the PFA and the DMH are 
known as the center for defense response and is 
sometimes called the “defense area” [13].
Pioneering work by Hess [14] showed that elec-
trical stimulation of the posterior hypothalamus in 
cats elicited behavioral rage along with the specific 
autonomic responses that was termed the defense 
response. Although some reports using chemical stim-
ulation with excitatory amino acids (e.g., glutamate) 
had shown no effect or even a depressor effect [15,16], 
it was later shown that the negative results might have 
been caused by the stimulation of specific subregions 
in the posterior hypothalamus and/or dosage of drugs 
[17]. In fact, the PFA was the most reliable region to 
elicit cardiovascular defense response [13] and over-
dose of excitatory amino acids sometimes inhibited 
neuronal activity, an effect known as excitation block 
phenomenon [18]. Disinhibition with a GABAA recep-
tor antagonist, bicuculline methiodide, of the PFA re-
liably and dose-dependently induced the defense 
response [19]. Moreover, injection of a GABA agonist 
Fig. 1 — Hypothetical neural circuit for the defense response 
against stressors. Note that what are depicted here are 
only the circuits relevant to this review. See also Fig. 2 
and Section 3 on ‘Emotional behavior’. Ant. PIT = anterior 
pituitary; Temp. = temperature; DH = dorsal horn; DMH =
dorsomedial hypothalamus; IML = intermediolateral cell 
column; MLR = medullary locomotor region; PAG = periaq-
ueductal gray; PFA = perifornical area; PVN = paraventricular 
nucleus; RVLM = rostral ventrolateral medulla; RVMM = ros-
tral ventromedial medulla; SC = spinal cord; Sympa. = sym-
pathetic nerve; VH = ventral horn; VRG = ventral respiratory 
group.
MLR PAG
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to the defense area inhibited stress-induced rise in 
arterial pressure (AP) and heart rate (HR) [20].
Sympathoexcitatory cardiovascular response is not 
the sole characteristic of the defense response. The 
defense response is characterized by a coordinated 
rise in AP, HR, respiratory frequency, and resistance in 
the visceral vascular beds along with a fall in resist-
ances in airway and blood vessels in the skeletal mus-
cles when an animal encounters stressors. Baroreceptor 
reflex is suppressed or reset to a higher-pressure range 
to allow higher AP than that in resting condition. More-
over, body temperature increases [21], cortical arousal 
is promoted, and the sensation of pain is actively sup-
pressed during the defense response. All these changes 
support the efficiency of the behavioral response of 
fight or flight (Fig. 2) [11,13,22].
Some neurotransmitters have been proposed to be 
involved in the efferent pathways of the defense re-
sponse. For example, activation of serotonin (5HT)-1A 
receptors in the medullary raphe reduced cardiovas-
cular changes [23] and inhibition of 5HT-3 receptors 
in the nucleus tractus solitarius prevented the barore-
flex bradycardia inhibition during the defense response 
[24]. Microinjections of adenosine into the rostral ven-
trolateral medulla augmented the increase in AP evoked 
by electrical stimulation of the hypothalamic defense 
area [25]. Pros and cons were reported on participation 
of glutamate in the cardiovascular component of the 
defense response [26,27]. To date, however, there are 
no reports on the molecular basis of the defense re-
sponse underlying its multifaceted nature of simul-
taneous and coordinated changes in cardiovascular, 
respiratory, sensory, and behavioral parameters.
We hypothesized that intrinsic orexin, synthesized in 
the PFA/DMH, regulates the multifaceted features of the 
defense response. In fact, stress activated orexiner-
gic neurons [28–32]. Pharmacological and anatomical 
evidence supports our hypothesis. Exogenous admin-
istration of orexin induced analgesia [33] and cardio-
vascular [34–39] and respiratory [39,40] activation. 
Orexinergic neurons projected to the cardiovascular 
centers [34,41–44], respiratory centers [40,45], and 
sympathetic premotor neurons controlling brown adi-
pose tissue [46,47] in the medulla oblongata and the 
spinal cord. About 50% of the hypothalamic neurons 
that innervate both sympathetic efferent and motor 
cortex or medial prefrontal cortex, which is implicated 
in mental stress, showed orexin-like immunoreactivity 
[48,49]. Numerous neurons in the amygdala, a putative 
center for biological value judgment [50], were retro-
gradely labeled by trans-synaptic transport of tetanus 
toxin expressed by the orexin promoter [51].
4. Evidence for participation of orexin 
in the defense response
To test our hypothesis that orexin contributes to the 
multiple efferent pathways of the defense response, 
we performed several lines of experiments using ge-
netically engineered orexin-deficient mice. At present, 
there are two genetically engineered mice models of 
orexin deficiency to study the possible roles of intrin-
sic orexin in physiological functions. One is the prepro-
orexin knockout mouse (ORX-KO) that was developed 
by a conventional knockout technique [52] and an-
other is the orexin neuron-ablated mouse [53]. The 
latter was developed using a transgenic technique by 
introducing a truncated Machado-Joseph disease gene 
product (ataxin-3) with an expanded polyglutamine 
Fig. 2 — Multifaceted nature of the defense response. Simultaneous and coordinated changes in the cardiorespiratory, 
sensory and thermoregulatory systems support the efficiency of the behavioral fight-or-flight response. Orexin plays 
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stretch under the control of the orexin promoter. In 
these orexin/ataxin-3 transgenic mice (ORX/ATX-Tg), 
orexinergic neurons are selectively and postnatally 
degenerated and reaches > 99% loss at 4 months of 
age [53]. In these mice, not only orexin but also other 
neurotransmitter candidates contained in the orexin-
ergic neurons, such as dynorphin, galanin, and gluta-
mate, are considered deficient [54]. Both ORX-KO and 
ORX/ATX-Tg showed a phenotype strikingly similar to 
human narcolepsy [52,53]. The data described below 
were obtained from offspring of the originally described 
ORX-KO [52] and ORX/ATX-Tg [53] in which the geno-
types and orexin deficiency were confirmed.
4.1. Stimulation to the PFA resulted in an 
attenuated defense response in 
ORX-KO and ORX/ATX-Tg
As stated above, the defense response is character-
ized not only by increases in AP and HR but also by 
increases in ventilation and cortical arousal and by 
shift of blood flow from visceral to skeletal vascula-
ture. To test our hypothesis that orexin contributes to 
expression of all the features of the defense response, 
we compared the effects of chemical stimulation of the 
PFA by bicuculline on the above-mentioned parame-
ters among ORX-KO, ORX/ATX-Tg and wild-type (WT) 
Fig. 3 — Effects of microinjection of bicuculline methiodide to the perifornical area in wild-type (WT) mice and orexin/
ataxin-3 transgenic mice (Tg) on arterial blood pressure, heart rate, respiratory minute ventilation, and the muscular and 
visceral vascular conductance. Arrowheads indicate timing of microinjection of bicuculline (20 nL). Data are presented 
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mice. As expected, increases in AP, HR, respiratory 
frequency, and β-band power of electroencephalogram 
(an index of cortical arousal) were smaller and/or 
shorter-lasting in ORX-KO than in WT littermates [55]. 
In a similar manner, increases in AP, HR, and respira-
tory minute volume and vascular dilatation in skeletal 
muscle were attenuated in ORX/ATX-Tg mice (Fig. 3) 
[56]. Therefore, we concluded that orexin-containing 
neurons in the PFA play a role as a master switch to 
activate multiple efferent pathways of the defense re-
sponse. Orexin but not cotransmitters in the neurons 
seemed to be important at least for the changes in 
AP, HR and respiration.
4.2. Suppression of the baroreceptor reflex 
during the defense response was also 
attenuated in ORX/ATX-Tg mice
During the defense response, baroreceptor reflex is 
suppressed or reset to a higher pressure range to allow 
higher AP than that in resting condition. This is another 
important feature of the defense response to ensure 
effective behavior of fight or flight. To test whether 
the suppression of the baroreceptor reflex was nor-
mal or not in ORX-deficient mice, we performed two 
lines of experiments.
First, the baroreceptor reflex under the resting 
condition (i.e., without stimulation to elicit the defense 
response) was compared between ORX/ATX-Tg and 
WT littermates. To do so, a naturally occurring se-
quence method [57] was employed. In brief, record-
ings of AP from unanesthetized animals were scanned 
by a home-made computer program to identify the 
spontaneous sequences of three or more consecutive 
beats in which systolic AP (SAP) progressively in-
creased or decreased by more than 1 mmHg per beat. 
Of these SAP sequences, those that were associated 
with baroreflex-driven lengthening or shortening in 
the RR intervals of electrocardiographic signals were 
selected and defined as baroreflex sequences. A lin-
ear regression analysis between SAP and RR interval 
Fig. 4 — Typical example of the inhibitory effect of perifornical area (PFA) stimulation on baroreflex bradycardia in wild-type
(WT) mice and orexin/ataxin-3 transgenic mice (Tg). (LEFT) PFA was electrically stimulated for 30 seconds (PFA stim, hori-
zontal bar) after pretreatment with atenolol (5 mg/kg, i.p.). (MIDDLE) Baroreflex bradycardia was induced by an intravenous 
injection of phenylephrine (50 mg/kg, PE inj, arrow). (RIGHT) PE-induced bradycardia was reduced by simultaneous PFA 
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was applied to each baroreflex sequence, and the 
slope of the regression line was calculated. An average 
value of the slopes in a mouse was taken as the gain 
of baroreflex in the animal. We also calculated the 
baroreflex effectiveness index, defined as the ratio 
between the number of baroreflex sequences and the 
total number of SAP ramps regardless of the possible 
occurrence of concomitant reflex change in RR inter-
vals [58]. There was no statistically significant differ-
ence between ORX/ATX-Tg and WT littermates in the 
slope of the regression line, i.e., gain of the barore-
ceptor reflex, and the baroreflex effectiveness index. 
In addition, the number of SAP ramps was compara-
ble between the mutant and WT mice, showing that 
overall fluctuations in AP were similar between both 
genotypes.
In the second series of experiments, we examined 
the baroreceptor reflex during activation of the PFA by 
either electrical or chemical stimulus. We used anes-
thetized mice because stimulation to the PFA was dif-
ficult in awake animals. To observe vagally-mediated 
reflex bradycardia, the animals were pretreated with 
intraperitoneal injection of a β-blocker, atenolol. Baro-
reflex bradycardia was induced by a rise in AP with 
an intravenous injection of phenylephrine. In WT mice, 
the combination of PFA stimulation and phenylephrine 
injection elicited only a small decrease in HR, although 
injection of phenylephrine alone induced a large de-
crease in HR. In ORX/ATX-Tg mice, on the other hand, 
phenylephrine induced a large decrease in HR irrespec-
tive of PFA stimulation (Fig. 4) [56]. Therefore, orexin 
seemed to contribute to baroreflex suppression dur-
ing the defense response but not during the resting 
condition.
4.3. Attenuation of the defense response 
in ORX-KO and ORX/ATX-Tg mice was 
observed with natural stimulation
To exclude the possibility that the observed differ-
ence between orexin-deficient mice and WT litterma-
tes were due to the difference in their susceptibility 
to an anesthetic, we tested the defense response in 
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conscious animals. In this experiment, we used natu-
ral stimulation rather than artificial stimulation to the 
PFA. For this purpose, we used a resident-intruder test 
or air-jet stress paradigm with telemeter-implanted 
animals. As expected, emotional stressor-induced in-
creases in AP, HR, and locomotor activity were smaller 
in orexin-deficient mice (ORX-KO and ORX/ATX-Tg) 
than in WT littermates (Fig. 5) [55,56].
4.4. Attenuated stress-induced analgesia in 
ORX-KO mice
In the last series of experiments, we examined foot 
shock stress-induced analgesia in the mutant mice. 
In the WT mice, foot shock induced long-lasting anal-
gesia as evidenced by increases in tail flick latency 
from noxious hot water. Although the ORX-KO mice 
showed moderate analgesia, it was significantly smaller 
than in WT littermates [30]. In line with this result, we 
observed numerous expression of c-fos, a marker 
for cellular activation, in neurons with orexin-like 
immunoreactivity after the foot shock.
5. Conclusions
Here, we summarized evidence showing the possi-
ble contribution of orexin in the defense response. 
Atten uation of all features of the defense response 
so far tested in orexin-deficient mice points to the 
notion that orexin acts as a master switch to elicit 
orchestrated changes in the defense response 
against stressors. This notion is not yet conclusive 
since our results were obtained from a mixture of 
experiments using different animal models and com-
pensation cannot be denied. However, phenotypes 
of ORX-KO and ORX/ATX-Tg mice were very similar 
so far tested (i.e., narcolepsy, decreased food intake, 
and some features of the defense response). Possible 
developmental compensation in utero can be denied 
since neuronal degeneration in ORX/ATX-Tg begins 
1–2 weeks after birth [53]. More over, supplementa-
tion of orexin rescued respiratory ab normality in 
ORX-KO [59]. There fore, we believe that the above 
notion would need very slight revision, if any.
Another feature of the defense response that has 
not yet been examined in orexin-deficient mice is the 
Fig. 5 — Cardiovascular and behavioral responses during natural stressful stimulation in conscious orexin-deficient 
mice and their wild-type (WT) littermates. (A) Resident-intruder test was performed in radio telemeter-indwelled freely 
moving WT and orexin knockout (ORX-KO) mice. The presence of an intruder is indicated by the horizontal solid bar. 
Right side panels are the changes in blood pressure, heart rate, and activity expressed as area under the curve (AUC) 
during 5 minutes when an intruder was present in the same cage. (B) Air jet stress was applied to catheter-indwelling 
lightly restrained WT and orexin/ataxin-3 transgenic (ORX/ATX-Tg) mice. Duration of air jet stress is indicated by the 
horizontal solid bar. Right side panels are the changes in arterial pressure and heart rate expressed as AUC during 
5 minutes of the stress. Data are presented as mean ± standard error of 6–8 mice in each genotype. *p< 0.05 and 
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increase in body temperature. Rise in body tempera-
ture accelerates nerve conduction velocity and thus 
supports fight-or-flight behavior. There is only one 
paper that deals with the possible role of orexin in 
temperature regulation [60]. Mochizuki et al reported 
that temperature drop during sleep was attenuated 
in ORX-KO mice. Therefore, orexin may serve to de-
crease rather than increase body temperature, at 
least during sleep. But how about during the defense 
response? We think this theme should be examined 
in the near future.
The diversity of synaptic control of the cardiovas-
cular and respiratory neurons seems necessary for 
animals to adapt themselves toward ever-changing life 
circumstances and behavioral states. The orexin sys-
tem is likely to work as one of the essential modula-
tors for coordinating circuits controlling autonomic 
functions and behavior.
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